Entera Bio to Participate in the SVB Securities Global Biopharma Conference
13 févr. 2023 09h00 HE
|
Entera Bio Ltd.
JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a late-clinical stage, leader in the development of orally delivered peptides and therapeutic...
2022 Updates on the Impact of COVID-19 on Clinical Trials: Assess Companies Future Plans to Use Decentralized Clinical Trials
08 févr. 2023 12h58 HE
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2022 Update" report has been added to ResearchAndMarkets.com's offering.This PowerPoint...
Clinical Trial Supplies Global Market Report 2022: Sector to Reach $3.3 Billion by 2027 at a CAGR of 7.82%
08 févr. 2023 10h28 HE
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Clinical Trials Management Services Market Report 2022 - Global Industry Size, Share, Trends, Opportunities, and Forecast to 2027
08 févr. 2023 09h33 HE
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trials Management Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Service Type, By...
INmune Bio, Inc. Receives Approximately $6.4 Million in Research and Development Rebates from Australia and the United Kingdom
08 févr. 2023 08h45 HE
|
INmune Bio, Inc.
BOCA RATON, Fla., Feb. 08, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s...
GeoVax Expands Gedeptin® Clinical Research for Advanced Head and Neck Cancers
07 févr. 2023 09h00 HE
|
GeoVax, Inc.
Phase 1/2 Trial Now Active at Stanford, Emory, and Thomas Jefferson Universities ATLANTA, GA, Feb. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology...
Clinical Trials Market to Surpass US$ 177.7 Billion Valuation by 2033 Owing to the Development of Precision Medicines and Therapeutic Approaches | Future Market Insights, Inc.
07 févr. 2023 08h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The global Clinical Trials Market is anticipated to augment at a flourishing CAGR of 4.41% over the forecast period from 2023 to 2033. The global...
PDS Biotech Announces Abstract Accepted for Presentation at ESMO Targeted Anticancer Therapies Congress
06 févr. 2023 08h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., Feb. 06, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
Endogena Therapeutics Receives US FDA Fast Track Designation for EA-2353 for the Treatment of Retinitis Pigmentosa
06 févr. 2023 07h00 HE
|
Endogena
SAN FRANCISCO, TORONTO and ZÜRICH, Switzerland, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Endogena Therapeutics Inc., a clinical-stage biotech company focused on the development of endogenous...
EU (European Union) Clinical Trial Regulation 536/2014 Overview and Implementation Training Course (February 23-24, 2023)
02 févr. 2023 11h28 HE
|
Research and Markets
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "EU (European Union) Clinical Trial Regulation 536/2014: Overview and Implementation Training Course" conference has been added to ...